AngioDynamics Inc. announced unaudited consolidated earnings results for the second quarter and six months ended November 30, 2018. For the quarter, the company's net sales were $91,503,000 against $86,706,000 a year ago. Operating income was $3,981,000 against $1,123,000 a year ago. Net income was $2,140,000 against $249,000 a year ago. Earnings per basic and diluted share were $0.06 against $0.01 a year ago. Adjusted diluted EPS was $0.22 against $0.17 a year ago.

For the six months, the company's net sales were $176,843,000 against $172,117,000 a year ago. Operating income was $4,307,000 against $1,263,000 a year ago. Net income was $1,671,000 against $214,000 a year ago. Earnings per basic and diluted share were $0.04 against $0.01 a year ago. Adjusted diluted EPS was $0.38 against $0.30 a year ago.

For the fiscal year 2019, the Company reiterates its financial guidance, continuing to expect net sales in the range of $354 million to $359 million. Additionally, the Company continues to expect adjusted earnings per share in the range of $0.82 to $0.86.